ATG-101 is a tetravalent PD-L1×4-1BB bispecific antibody that stimulates anti-tumor immunity through PD-L1 blockade and PD-L1-directed 4-1BB activation
Used in this study: B-h4-1BB mice
Read entire articleUsed in this study: B-h4-1BB mice
Read entire article